Results
|
41.
|
|
|
42.
|
|
|
43.
|
|
|
44.
|
|
|
45.
|
|
|
46.
|
|
|
47.
|
|
|
48.
|
|
|
49.
|
|
|
50.
|
|
|
51.
|
|
|
52.
|
|
|
53.
|
|
|
54.
|
Synthesis of potent and orally active HIV-protease inhibitors. [electronic resource] by
- Capraro, H G
- Bold, G
- Fässler, A
- Cozens, R
- Klimkait, T
- Lazdins, J
- Mestan, J
- Poncioni, B
- Rösel, J L
- Stover, D
- Lang, M
Producer: 19961127
In:
Archiv der Pharmazie vol. 329
Availability: No items available.
|
|
55.
|
Profile of CGP 61755: a novel and potent HIV-1 protease inhibitor that shows enhanced anti-HIV activity when combined with other antiretroviral agents in vitro. [electronic resource] by
- Lazdins, J K
- Bold, G
- Capraro, H G
- Cozens, R
- Fässler, A
- Flesch, G
- Klimkait, T
- Lang, M
- Mestan, J
- Poncioni, B
- Rösel, J
- Stover, D
- Tintelnot-Blomley, M
- Walker, M R
- Woods-Cook, K
Producer: 19970129
In:
Schweizerische medizinische Wochenschrift vol. 126
Availability: No items available.
|
|
56.
|
New aza-dipeptide analogues as potent and orally absorbed HIV-1 protease inhibitors: candidates for clinical development. [electronic resource] by
- Bold, G
- Fässler, A
- Capraro, H G
- Cozens, R
- Klimkait, T
- Lazdins, J
- Mestan, J
- Poncioni, B
- Rösel, J
- Stover, D
- Tintelnot-Blomley, M
- Acemoglu, F
- Beck, W
- Boss, E
- Eschbach, M
- Hürlimann, T
- Masso, E
- Roussel, S
- Ucci-Stoll, K
- Wyss, D
- Lang, M
Producer: 19980917
In:
Journal of medicinal chemistry vol. 41
Availability: No items available.
|
|
57.
|
New anilinophthalazines as potent and orally well absorbed inhibitors of the VEGF receptor tyrosine kinases useful as antagonists of tumor-driven angiogenesis. [electronic resource] by
- Bold, G
- Altmann, K H
- Frei, J
- Lang, M
- Manley, P W
- Traxler, P
- Wietfeld, B
- Brüggen, J
- Buchdunger, E
- Cozens, R
- Ferrari, S
- Furet, P
- Hofmann, F
- Martiny-Baron, G
- Mestan, J
- Rösel, J
- Sills, M
- Stover, D
- Acemoglu, F
- Boss, E
- Emmenegger, R
- Lässer, L
- Masso, E
- Roth, R
- Schlachter, C
- Vetterli, W
Producer: 20000724
In:
Journal of medicinal chemistry vol. 43
Availability: No items available.
|
|
58.
|
PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration. [electronic resource] by
- Wood, J M
- Bold, G
- Buchdunger, E
- Cozens, R
- Ferrari, S
- Frei, J
- Hofmann, F
- Mestan, J
- Mett, H
- O'Reilly, T
- Persohn, E
- Rösel, J
- Schnell, C
- Stover, D
- Theuer, A
- Towbin, H
- Wenger, F
- Woods-Cook, K
- Menrad, A
- Siemeister, G
- Schirner, M
- Thierauch, K H
- Schneider, M R
- Drevs, J
- Martiny-Baron, G
- Totzke, F
Producer: 20000511
In:
Cancer research vol. 60
Availability: No items available.
|